← All news
Event
Open registration: COINS Act & BINSA webinar with Frank Gao, July 4
NAPPA's Healthcare & Biopharma Insights series opens on July 4 with a one-hour briefing on the COINS Act, BINSA, and their implications for Chinese biopharma.
NAPPA’s signature thought-leadership webinar series — NAPPA Healthcare & Biopharma Insights — opens on Saturday, July 4, 2026, 8:00–9:00 PM ET with a focused analysis of two U.S. legal developments that matter for any Chinese biopharma company operating across borders.
The episode is led by Frank Gao, JD, patent attorney at Ladas & Parry LLP and NAPPA’s Midwest Regional Director.
What’s covered
- What is the COINS Act?
- What is BINSA?
- Impact on Chinese biopharma companies
- Licensing, technology transfer, and IP strategy implications
- Cross-border investment outlook
- Opportunities and risk mitigation
Register
Registration is free for NAPPA members and qualified industry guests. Join details are sent by email immediately after registering.
Tags
Webinar SeriesCOINS ActBINSALegal & IP